Review finds vitamin D lacks disease-modifying effect in rheumatic diseases

	Arthritis
	The latest arthritis news from News Medical

	Review finds vitamin D lacks disease-modifying effect in rheumatic diseases A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a comprehensive evaluation of the role of vitamin D in inflammatory rheumatic diseases.

	Existing drug mitigates muscle loss from GLP-1 medications Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss.

			GLP-1 therapies linked to fewer complications in adults with both obesity and autoimmune disease Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an...

			EULAR 2026 highlights rising comorbidity risks in rheumatic disease People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures.

			Real-world study exposes suboptimal adherence to treat-to-target rheumatic strategies EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to complement knowledge from randomized controlled trials.

	Patient organizations strengthen support for people with rheumatic diseases Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

	CAR-T cell therapy shows promise for treating rheumatoid arthritis Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

	GLP-1 treatments may reduce knee replacement surgery rates GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly lower long term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open access journal Regional Anesthesia & Pain Medicine.

	EULAR Congress highlights innovative support strategies for rheumatology patients Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.

	Continuing gout therapy during remission lowers future flare risk The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the agenda.

	Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes predictive of therapeutic response.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026